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SCF-KIT Pathway in Human Epidermal Melanocyte
Homeostasis
To the Editor:
In the August issue of the Journal of Investigative Dermatology,
Grichnik et al (1998) demonstrated the responsiveness of adult
human melanocytes to stem cell factor (SCF) in vivo. We have
been interested in the role of SCF in postnatal skin since we
discovered the production of SCF by human keratinocytes, and
noted that the presence of the soluble form of SCF is associated
with locally increased pigment production in the epidermis of
patients with urticaria pigmentosa (Longley et al, 1993). These
observations first implicated local production of SCF in postnatal
melanocyte function. We agree with Grichnik et al (1998) that
their current findings are further evidence of the fundamental role
played by the SCF-KIT pathway in the regulation of melanocyte
proliferation and differentiation in human postnatal skin.
We would like to take this opportunity, however, to focus
discussion on the difference between the role of soluble SCF,
studied by Grichnik et al (1995) and others (Costa et al, 1996;
Grichnik et al, 1998), and the role of membrane-bound ker-
atinocyte-associated SCF. The majority of the immunoreactive
SCF found in normal human skin is bound to keratinocyte cell
membranes rather than being present in a soluble form, as originally
observed by us (Longley et al, 1993) and confirmed by others
(Hamann et al, 1995). Membrane-bound SCF and soluble SCF
have different effects on cells (Toksoz et al, 1992; Miyazawa et al,
1995), so the distinction may be important in vivo. In particular,
based on the following observations it appears that soluble SCF is
insufficient to support the normal migration and maintenance of
melanocytes in the skin.
Sl/Sld mice, whose cells produce only soluble SCF, are white
and have no melanocytes in the epidermis or hair follicles, indicating
that the soluble form of the molecule is incapable of supporting
melanocyte development and function (Silvers, 1979; Anderson
et al, 1990).
In normal mice, the gene for SCF is expressed in the epidermis
during development but not postnatally (Yoshida et al, 1996).
Consequently, the number of melanocytes (and melanoblasts)
present in the epidermis declines rapidly in the first few days
after birth, so that essentially no melanocytes are present in the
interfollicular epidermis of the adult mouse (Hirobe, 1984). The
color of the adult mouse therefore is a product of melanocytes that
are active in the hair follicles rather than the epidermis, which
lacks melanocytes and is unpigmented. This situation differs mark-
edly from human skin, in which epidermal keratinocytes express
SCF and melanocytes are maintained postnatally. We have recently
demonstrated the dominance of the membrane-associated form of
SCF using transgenic mice that express SCF in the basal layer of
the epidermis (Kunisada et al, 1998a). These studies show that the
membrane-bound form of SCF is required for melanocyte survival
in the epidermis, and that its expression in murine epidermis results
in the population of the epidermis by melanocytes. Thus, epidermal
membrane-bound SCF is both sufficient and necessary for normal
melanocyte function in the epidermis. Soluble SCF, it appears, is
associated with hyperfunction of melanocytes.
Also of relevance to the work of Grichnik et al (1996, 1998) are
studies using similar strains of the transgenic mice (Kunisada et al,
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1998b), which point to the presence of a cutaneous melanocyte
‘stem cell’ that, in mice, is not dependent on activation of KIT.
Whether these cells do not express the KIT receptor or are merely
not dependent on KIT activation for survival remains to be
determined experimentally; however, it would be interesting to
know whether the KIT-positive, TRP-1-negative cells described
by Grichnik et al (1996) are dependent on KIT for their survival.
One might expect to find melanocyte stem cells in the hair follicles
of normal mice, because there is no indication that melanocyte
stem cells are present in the interfollicular epidermis of nontrans-
genic mice.
B. Jack Longley and Eric L. Carter
Columbia University College of Physicians & Surgeons, New
York, New York, USA
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Reply
Given the current understanding of SCF expression patterns, we
believe, as Drs Longly and Carter suggest, that the keratinocyte
bound form of SCF will be the primary player in the control of
normal human melanocyte homeostasis in the epidermis.
As Drs Longley and Carter point out, SCF has two known splice
forms. Both SCF forms are initially expressed as membrane bound
proteins but one can be cleaved into a ‘‘soluble’’ form whereas the
other remains bound on the cell surface due to the absence of an
exon. The region involved in KIT activation is the same for both
